Robert Pordy

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 21

Top Venues

European heart journal

Nature medicine

European heart journal. Cardiovascular pharmacotherapy

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Gaudet, Susanne Greber-Platzer, Laurens F Reeskamp, Gabriella Iannuzzo, Robert S Rosenson, Samir Saheb, Claudia Stefanutti, Erik Stroes, Albert Wiegman, Traci Turner, Shazia Ali, Poulabi Banerjee, Tiera Drewery, Jennifer McGinniss, Alpana Waldron, Richard T George, Xue-Qiao Zhao, Robert Pordy, Jian Zhao, Eric Bruckert, Frederick J Raal
Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy. European heart journal (2024)
Shaun G Goodman, Philippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Robert A Harrington, Johan Wouter Jukema, Harvey D White, Andreas M Zeiher, Garen Manvelian, Robert Pordy, Yann Poulouin, Wanda Stipek, Genevieve Garon, Gregory G Schwartz, null null
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Shaun G Goodman, Philippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Robert A Harrington, Johan Wouter Jukema, Harvey D White, Andreas M Zeiher, Garen Manvelian, Robert Pordy, Yann Poulouin, Wanda Stipek, Genevieve Garon, Gregory G Schwartz, null null
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Robert Dingman, Sébastien Bihorel, Viktoria Gusarova, Jeanne Mendell, Robert Pordy
Evinacumab: Mechanism of action, clinical, and translational science. Clinical and translational science 17 (6) (2024)
Daniel Gaudet, Susanne Greber-Platzer, Laurens F Reeskamp, Gabriella Iannuzzo, Robert S Rosenson, Samir Saheb, Claudia Stefanutti, Erik Stroes, Albert Wiegman, Traci Turner, Shazia Ali, Poulabi Banerjee, Tiera Drewery, Jennifer McGinniss, Alpana Waldron, Richard T George, Xue-Qiao Zhao, Robert Pordy, Jian Zhao, Eric Bruckert, Frederick J Raal
Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy. European heart journal 45 (27) (2024)
Robert Dingman, Sébastien Bihorel, Viktoria Gusarova, Jeanne Mendell, Robert Pordy
Evinacumab: Mechanism of action, clinical, and translational science. Clinical and translational science 17 (6) (2024)
Daniel Gaudet, Susanne Greber-Platzer, Laurens F Reeskamp, Gabriella Iannuzzo, Robert S Rosenson, Samir Saheb, Claudia Stefanutti, Erik Stroes, Albert Wiegman, Traci Turner, Shazia Ali, Poulabi Banerjee, Tiera Drewery, Jennifer McGinniss, Alpana Waldron, Richard T George, Xue-Qiao Zhao, Robert Pordy, Jian Zhao, Eric Bruckert, Frederick J Raal
Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy. European heart journal 45 (27) (2024)
Shaun G Goodman, Philippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Robert A Harrington, Johan Wouter Jukema, Harvey D White, Andreas M Zeiher, Garen Manvelian, Robert Pordy, Yann Poulouin, Wanda Stipek, Genevieve Garon, Gregory G Schwartz
Safety Of The Pcsk9 Inhibitor Alirocumab: insights From 47,296 Patient-Years Of Observation. European heart journal. Cardiovascular pharmacotherapy (2024)
Robert Dingman, Sébastien Bihorel, Viktoria Gusarova, Jeanne Mendell, Robert Pordy
Evinacumab: Mechanism of action, clinical, and translational science. Clinical and translational science 17 (6) (2024)
Shaun G Goodman, Philippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Robert A Harrington, Johan Wouter Jukema, Harvey D White, Andreas M Zeiher, Garen Manvelian, Robert Pordy, Yann Poulouin, Wanda Stipek, Genevieve Garon, Gregory G Schwartz, null null
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Daniel Gaudet, Susanne Greber-Platzer, Laurens F Reeskamp, Gabriella Iannuzzo, Robert S Rosenson, Samir Saheb, Claudia Stefanutti, Erik Stroes, Albert Wiegman, Traci Turner, Shazia Ali, Poulabi Banerjee, Tiera Drewery, Jennifer McGinniss, Alpana Waldron, Richard T George, Xue-Qiao Zhao, Robert Pordy, Jian Zhao, Eric Bruckert, Frederick J Raal
Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy. European heart journal 45 (27) (2024)
Robert S Rosenson, Daniel Gaudet, Christie M Ballantyne, Seth J Baum, Jean Bergeron, Erin E Kershaw, Patrick M Moriarty, Paolo Rubba, David C Whitcomb, Poulabi Banerjee, Andrew Gewitz, Claudia Gonzaga-Jauregui, Jennifer McGinniss, Manish P Ponda, Robert Pordy, Jian Zhao, Daniel James Rader
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. Nature medicine 29 (3) (2023)
Gregory G Schwartz, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Maja Bujas-Bobanovic, Rafael Diaz, Sergio Fazio, Zlatko Fras, Shaun G Goodman, Robert A Harrington, Johan Wouter Jukema, Garen Manvelian, Robert Pordy, Kausik K Ray, Michel Scemama, Harvey D White, Ph Gabriel Steg, null null
Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial. European heart journal (2023)
Robert S Rosenson, Daniel Gaudet, Christie M Ballantyne, Seth J Baum, Jean Bergeron, Erin E Kershaw, Patrick M Moriarty, Paolo Rubba, David C Whitcomb, Poulabi Banerjee, Andrew Gewitz, Claudia Gonzaga-Jauregui, Jennifer McGinniss, Manish P Ponda, Robert Pordy, Jian Zhao, Daniel James Rader
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. Nature medicine (2023)
Albert Wiegman, Susanne Greber-Platzer, Shazia Ali, M Doortje Reijman, Eliot A Brinton, Min-Ji Charng, Shubha Srinivasan, Carissa M Baker-Smith, Seth J Baum, Julie A Brothers, Jacob Hartz, Patrick M Moriarty, Jeanne Mendell, Sébastien Bihorel, Poulabi Banerjee, Richard T George, Boaz Hirshberg, Robert Pordy
Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia. Circulation (2023)
Robert S Rosenson, Daniel Gaudet, Christie M Ballantyne, Seth J Baum, Jean Bergeron, Erin E Kershaw, Patrick M Moriarty, Paolo Rubba, David C Whitcomb, Poulabi Banerjee, Andrew Gewitz, Claudia Gonzaga-Jauregui, Jennifer McGinniss, Manish P Ponda, Robert Pordy, Jian Zhao, Daniel James Rader
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. Nature medicine 29 (3) (2023)
Robert S Rosenson, Daniel Gaudet, Christie M Ballantyne, Seth J Baum, Jean Bergeron, Erin E Kershaw, Patrick M Moriarty, Paolo Rubba, David C Whitcomb, Poulabi Banerjee, Andrew Gewitz, Claudia Gonzaga-Jauregui, Jennifer McGinniss, Manish P Ponda, Robert Pordy, Jian Zhao, Daniel James Rader
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. Nature medicine 29 (3) (2023)
Ulf Landmesser, Jennifer McGinniss, Ph Gabriel Steg, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Mirza Dilic, Shaun G Goodman, J Wouter Jukema, Megan Loy, Ivan Pećin, Robert Pordy, Steen H Poulsen, Michael Szarek, Harvey D White, Gregory G Schwartz, null null
Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab. European journal of preventive cardiology 29 (14) (2022)
Harvey D White, Gregory G Schwartz, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Chern-En Chiang, Rafael Diaz, Shaun G Goodman, Johan Wouter Jukema, Megan Loy, Neha Pagidipati, Robert Pordy, Arsen D Ristić, Andreas M Zeiher, Daniel M Wojdyla, Phillippe Gabriel Steg, null null
Alirocumab after acute coronary syndrome in patients with a history of heart failure. European heart journal 43 (16) (2022)
Emil Hagström, Phillippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Tabassome Simon, Rafael Diaz, Shaun G Goodman, Robert A Harrington, Johan Wouter Jukema, Evangelos N Liberopoulos, Nikolaus Marx, Jennifer McGinniss, Garen Manvelian, Robert Pordy, Michel Scemama, Harvey D White, Andreas M Zeiher, Gregory G Schwartz, null null
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. Circulation 146 (9) (2022)
William A Murphy, Nan Lin, Amy Damask, Gregory G Schwartz, Phillippe Gabriel Steg, Michael Szarek, Poulabi Banerjee, Sergio Fazio, Garen Manvelian, Robert Pordy, Alan R Shuldiner, Charles Paulding
Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial. Circulation. Genomic and precision medicine 15 (3) (2022)

Robert Pordy.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert Pordy